Marksans Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve financial results for the quarter ....
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has informed the stock exchanges that its Board of Directors will meet on Tuesday, August 12, 2025, in Mumbai. The main agenda is to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter ended June 30, 2025 (Q1 FY26). The trading window for designated persons and their immediate relatives has already been closed from July 1, 2025, and will remain closed until August 14, 2025, which is 48 hours after the results are announced. This is a routine regulatory filing under SEBI Listing Regulations to formally notify exchanges ahead of the results announcement.
No immediate impact on the stock. Investors should mark August 12, 2025, as the results date, as Q1 FY26 numbers could drive near-term price movement depending on performance versus expectations.